Skip to main content

Bacterial Infections in Chinchillas

Pocket Pet · Chinchilla lanigera · typical adult weight 0.40–0.80 kg

8 cited drugs treat Bacterial Infections in chinchillas: Amikacin, Azithromycin, Chloramphenicol, Ciprofloxacin, Clarithromycin, Marbofloxacin, Oxytetracycline, Tetracycline.

General coverage of susceptible bacterial pathogens. Drug selection turns on the suspected organism's gram-stain, the patient's species (oral β-lactams unsafe in rabbits/guinea pigs), and the infection site (penetration to bone, CSF, or biliary tree).

The overview above describes Bacterial Infections across species; the citations below are the ExoticRx dose rules scoped to chinchillas — a reference list, not new species-specific clinical guidance.

Amikacin(Amiglyde-V, Amikin)

Antibiotic
RouteDoseFrequencyIndicationEvidenceSource
SC, IM, IV5–15 mg/kgq8-12hGram-negative bacterial infectionWeakMeredith A. BSAVA Small Animal Formulary: Part B: Exotic Pets, British Small Animal Veterinary Association, Quedgeley, Gloucester, UK; 2015. — Source: Carpenter's Exotic Animal Formulary, 6th Ed, p.770 — Carpenter's Exotic Animal Formulary 6th ed, Table 9.1 (Antimicrobial and Antifungal Agents Used in Rodents.a). The copy held is an ebook conversion with no printed page numbers, so the table — not the page — is the citable location. — SOURCE EDITION: BSAVA Small Animal Formulary, Part B — Exotic Pets — ISBN 9781910443712, https://openlibrary.org/isbn/9781910443712; Carpenter's Exotic Animal Formulary — ISBN 9780323833929, https://openlibrary.org/isbn/9780323833929

Azithromycin(Zithromax)

Antibiotic
RouteDoseFrequencyIndicationEvidenceSource
PO30 mg/kgq24hBacterial infection, most commonly dental diseaseModerateMitchell M, Mans C. Retrospective evaluation of orally prescribed azithromycin in guinea pigs (Cavia porcellus) and chinchillas (Chinchilla lanigera): 131 cases (2009-2025). J Am Vet Med Assoc. 2026;264:1-4. doi:10.2460/javma.25.12.0873 https://europepmc.org/article/MED/41849821

Chloramphenicol

Antibiotic
RouteDoseFrequencyIndicationEvidenceSource
PO30–50 mg/kgq8-12hBacterial infection (broad-spectrum)WeakFehr M, Sassenburg L, Zwart P. Krankheiten der Heimtiere, 8th ed., Schluetersche Verlagsgesellschaft, Hannover, Germany; 2015. / 130. Morrisey JK, Carpenter JW. Formulary. In: Quesenberry KE, Carpenter JW, eds. Ferrets, Rabbits, and Rodents: Clinical Medicine and Surgery, 4th ed., Elsevier, St. Louis, MO; 2021:620-630. — Verified against Carpenter's Exotic Animal Formulary, 6th Ed, p.771 (2026-08-01). — Carpenter's Exotic Animal Formulary 6th ed, Table 9.1 (Antimicrobial and Antifungal Agents Used in Rodents.a). Located 2026-08-05: the only table covering this species in which the drug's own row prints this dose. The copy held is an ebook conversion with no printed page numbers, so the table is the citable location. — SOURCE EDITION: Carpenter's Exotic Animal Formulary — ISBN 9780323833929, https://openlibrary.org/isbn/9780323833929; Ferrets, Rabbits, and Rodents: Clinical Medicine and Surgery — ISBN 9780323484350, https://openlibrary.org/isbn/9780323484350

Ciprofloxacin(Cipro, Baytril)

Antibiotic
RouteDoseFrequencyIndicationEvidenceSource
PO5–25 mg/kgq12-24hBacterial infectionWeakMeredith A. BSAVA Small Animal Formulary: Part B: Exotic Pets, British Small Animal Veterinary Association, Quedgeley, Gloucester, UK; 2015. — Source: Carpenter's Exotic Animal Formulary, 6th Ed, p.771 — Carpenter's Exotic Animal Formulary 6th ed, Table 9.1 (Antimicrobial and Antifungal Agents Used in Rodents.a). The copy held is an ebook conversion with no printed page numbers, so the table — not the page — is the citable location. — SOURCE EDITION: BSAVA Small Animal Formulary, Part B — Exotic Pets — ISBN 9781910443712, https://openlibrary.org/isbn/9781910443712; Carpenter's Exotic Animal Formulary — ISBN 9780323833929, https://openlibrary.org/isbn/9780323833929

Clarithromycin(Biaxin)

Antibiotic
RouteDoseFrequencyIndicationEvidenceSource
PO15 mg/kgq12hBacterial infection (otitis media, S. pneumoniae)ModerateAlper CM, Doyle WJ, Seroky JT, et al. Efficacy of clarithromycin treatment of acute otitis media caused by infection withttpenicillin-susceptible, -intermediate, and -resistant Streptococcus pneumoniae in the chinchilla. Antimicrob Agents Chemother. 1996;40:1889-1892. — Source: Carpenter's Exotic Animal Formulary, 6th Ed, p.771 doi:10.1128/aac.40.8.1889 — Carpenter's Exotic Animal Formulary 6th ed, Table 9.1 (Antimicrobial and Antifungal Agents Used in Rodents.a). The copy held is an ebook conversion with no printed page numbers, so the table — not the page — is the citable location. — SOURCE EDITION: Carpenter's Exotic Animal Formulary — ISBN 9780323833929, https://openlibrary.org/isbn/9780323833929

Marbofloxacin(Zeniquin)

Antibiotic
RouteDoseFrequencyIndicationEvidenceSource
PO2–5 mg/kgq24hBacterial infectionWeakMeredith A. BSAVA Small Animal Formulary: Part B: Exotic Pets, British Small Animal Veterinary Association, Quedgeley, Gloucester, UK; 2015. — Verified against Carpenter's Exotic Animal Formulary, 6th Ed, p.772 (2026-08-01). — Carpenter's Exotic Animal Formulary 6th ed, Table 9.1 (Antimicrobial and Antifungal Agents Used in Rodents.a). The copy held is an ebook conversion with no printed page numbers, so the table — not the page — is the citable location. — SOURCE EDITION: BSAVA Small Animal Formulary, Part B — Exotic Pets — ISBN 9781910443712, https://openlibrary.org/isbn/9781910443712; Carpenter's Exotic Animal Formulary — ISBN 9780323833929, https://openlibrary.org/isbn/9780323833929

Oxytetracycline(Terramycin, Liquamycin)

Antibiotic
RouteDoseFrequencyIndicationEvidenceSource
IM15 mg/kgq12hBacterial infectionWeakMeredith A. BSAVA Small Animal Formulary: Part B: Exotic Pets, British Small Animal Veterinary Association, Quedgeley, Gloucester, UK; 2015. — Source: Carpenter's Exotic Animal Formulary, 6th Ed, p.773 — Carpenter's Exotic Animal Formulary 6th ed, Table 9.1 (Antimicrobial and Antifungal Agents Used in Rodents.a). The copy held is an ebook conversion with no printed page numbers, so the table — not the page — is the citable location. — SOURCE EDITION: BSAVA Small Animal Formulary, Part B — Exotic Pets — ISBN 9781910443712, https://openlibrary.org/isbn/9781910443712; Carpenter's Exotic Animal Formulary — ISBN 9780323833929, https://openlibrary.org/isbn/9780323833929
PO50 mg/kgq12hBacterial infectionWeakMeredith A. BSAVA Small Animal Formulary: Part B: Exotic Pets, British Small Animal Veterinary Association, Quedgeley, Gloucester, UK; 2015. — Source: Carpenter's Exotic Animal Formulary, 6th Ed, p.773 — Carpenter's Exotic Animal Formulary 6th ed, Table 9.1 (Antimicrobial and Antifungal Agents Used in Rodents.a). The copy held is an ebook conversion with no printed page numbers, so the table — not the page — is the citable location. — SOURCE EDITION: BSAVA Small Animal Formulary, Part B — Exotic Pets — ISBN 9781910443712, https://openlibrary.org/isbn/9781910443712; Carpenter's Exotic Animal Formulary — ISBN 9780323833929, https://openlibrary.org/isbn/9780323833929

Tetracycline(Panmycin)

Antibiotic
RouteDoseFrequencyIndicationEvidenceSource
PO10 mg/kgq8-12hBacterial infectionWeakMorrisey JK, Carpenter JW. Formulary. In: Quesenberry KE, Carpenter JW, eds. Ferrets, Rabbits, and Rodents: Clinical Medicine and Surgery, 4th ed., Elsevier, St. Louis, MO; 2021:620-630. — Source: Carpenter's Exotic Animal Formulary, 6th Ed, p.774 — Carpenter's Exotic Animal Formulary 6th ed, Table 9.1 (Antimicrobial and Antifungal Agents Used in Rodents.a). Located 2026-08-05: the only table covering this species in which the drug's own row prints this dose. The copy held is an ebook conversion with no printed page numbers, so the table is the citable location. — SOURCE EDITION: Carpenter's Exotic Animal Formulary — ISBN 9780323833929, https://openlibrary.org/isbn/9780323833929; Ferrets, Rabbits, and Rodents: Clinical Medicine and Surgery — ISBN 9780323484350, https://openlibrary.org/isbn/9780323484350

Sourced from published veterinary references; awaiting credentialed clinical reviewer. See our editorial process. Reference only — not veterinary advice. Verify against current literature before clinical use.